Case Studies
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential ...
Cannabist Strikes Deals to Exit Ohio and Delaware
CHELMSFORD – The Cannabist Co. Holdings Inc. signed definitive agreements ...
WSWA Launches Educational Resource on Hemp Beverage Regulation
WASHINGTON – The Wine & Spirits Wholesalers of America (WSWA), ...
Trump’s Rescheduling Order Ignites State Cannabis Momentum in Pennsylvania, Tennessee, and Wyoming
LOS ANGELES – President Donald Trump's directive last week to fast-track Cannabis's rescheduling has handed lawmakers in several conservative-leaning states a timely political opening to advance Cannabis reforms. The executive order, signed on December 18, ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Psilocybin Review Points to Rapid Relief for Treatment-Resistant Depression
LOS ANGELES – A new systematic review of clinical studies underscores psilocybin's potential to deliver quick and lasting reductions in depressive symptoms, offering a targeted option for patients who see little benefit from standard medications. ...
Vireo Takes 86% Stake in Schwazze’s Convertible Notes in $62M Deal
DENVER – Vireo Growth Inc., a multistate Cannabis operator, has entered into definitive agreements to purchase about 86% of the senior secured convertible notes held by Medicine Man Technologies Inc., which operates as Schwazze, for ...
France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
LOS ANGELES- Over the past decade, France has stood at the center of Europe’s fight to protect pollinators from the devastating effects of pesticides. In 2018, the nation became the first EU member to ban ...
OPINION: The People Have Spoken: It’s Time to End Federal Cannabis Prohibition (and Release the Epstein Files)
LOS ANGELES- With 87% of Americans supporting Cannabis legalization — and nearly 80% demanding the release of the Epstein files — public consensus on reform and transparency has never been stronger. The question now is ...
Trump’s Rescheduling Order Ignites State Cannabis Momentum in Pennsylvania, Tennessee, and Wyoming
LOS ANGELES – President Donald Trump's directive last week to fast-track Cannabis's rescheduling has handed lawmakers in several conservative-leaning states a timely political opening to advance Cannabis reforms. The executive order, signed on December 18, ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
